These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17245425)

  • 1. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation.
    Meyer E; Beyersmann J; Bertz H; Wenzler-Röttele S; Babikir R; Schumacher M; Daschner FD; Rüden H; Dettenkofer M;
    Bone Marrow Transplant; 2007 Feb; 39(3):173-8. PubMed ID: 17245425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project.
    Dettenkofer M; Wenzler-Röttele S; Babikir R; Bertz H; Ebner W; Meyer E; Rüden H; Gastmeier P; Daschner FD;
    Clin Infect Dis; 2005 Apr; 40(7):926-31. PubMed ID: 15824981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
    Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
    Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
    Laurenti L; Tarnani M; Chiusolo P; La Torre G; Garzia M; Zollino M; Zini G; Balducci M; Leone G; Sica S
    Clin Transplant; 2008; 22(2):191-9. PubMed ID: 18339139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients.
    Laws HJ; Kobbe G; Dilloo D; Dettenkofer M; Meisel R; Geisel R; Haas R; Göbel U; Schulze-Röbbecke R
    J Hosp Infect; 2006 Jan; 62(1):80-8. PubMed ID: 16242206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
    Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
    J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
    Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
    Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
    Auner HW; Zebisch A; Ofner P; Sill H; Linkesch W; Krause R
    Ann Hematol; 2005 Aug; 84(8):532-7. PubMed ID: 15809882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
    Worth LJ; Thursky KA; Seymour JF; Slavin MA
    Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies.
    Chaberny IF; Ruseva E; Sohr D; Buchholz S; Ganser A; Mattner F; Gastmeier P
    Ann Hematol; 2009 Sep; 88(9):907-12. PubMed ID: 19139891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.